Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 26, 2008

Lilly Beefs Up Biomarker Analysis Deal with HistoRx

  • Eli Lilly has gained broader use of HistoRx’ tissue biomarker analysis technology through a three-year extension. The expanded deal allows Lilly to increase its use of the Aqua® platform beyond the specified programs detailed in the 2005 agreement.

    Under the new alliance, HistoRx will also develop customized Aqua analysis-based immunohistochemical assays for Lilly to use in drug discovery and development projects.

    HistoRx has the option to commercialize the assays and reagents developed during the course of the partnership for clinical use as predictive diagnostics.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »